The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Voronina T.A.

NII farmakologii im. V.V. Zakusova RAMN, Moskva

Kapitsa I.G.

Zakusov Institute of Pharmacology, Moscow, Russia

Ivanova E.A.

Pirogov Russian National Research Medical University, Moscow, Russia

A comparative study of the effects of mexidolum and mildronatum on the physical performance of experimental animals

Authors:

Voronina T.A., Kapitsa I.G., Ivanova E.A.

More about the authors

Read: 96837 times


To cite this article:

Voronina TA, Kapitsa IG, Ivanova EA. A comparative study of the effects of mexidolum and mildronatum on the physical performance of experimental animals. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4):71‑74. (In Russ.)
https://doi.org/10.17116/jnevro20171174171-74

Recommended articles:
Study of drug-drug inte­ractions between Mexi­dol and thro­mbolytic drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):139-144
Brain aging: mole­cular targets of gero­protection and prevention stra­tegies. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):132-139
Multimodal antioxidant therapy in ischemic stroke: from MIR trial to bedside. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12-2):64-71
Pote­ntial for the six-minute walk test use in patients with atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(10):129-133

References:

  1. Sjakste N, Kalvinsh I. Mildronate: an antiischemic drug with multiple indications. Pharmacologyonline. 2006;1:1-18.
  2. Voronina TA. Antioksidant meksidol. Osnovnye neyropsikhotropnye effekty i mekhanizm deystviya. Psikhofarmakologiya i biologicheskaya narkologiya. 2001;1:2-12. (In Russ.).
  3. Voronina TA. Meksidol. Osnovnye neyropsikhotropnye effekty i mekhanizm deystviya. Farmateka. 2009;6:28-31. (In Russ.).
  4. Egorov EA, Davydova NG, Egorov EA, Davydova NG, Romanenko IA, Novikova ND. Mexidol in complex treatment of glaucoma RMJ oftalmologiya. 2011;3:107. (In Russ.). Accessed 08.02.17. Available at: http://www.rmj.ru/articles/oftalmologiya/Meksidol_v_kompleksnom_lechenii_glaukomy/#ixzz4XLmt7ouc
  5. Voronina TA. The role of oxidative stress and antioxidants in different disadapation genesis. Pharmacy and pharmacology. 2015;3(5):8-17. doi:10.19163/2307-9266-2015-3-5s
  6. Tregubova IA, Kosolapov VA, Spasov AA, Anisimova VA. Mnemotropic and anxiolytic activity of mexidol and enoxifol. Journal of New Medical Technologies, eEdition. 2015;9(4). (In Russ.). Accessed 08.02.17. Available at: http://medtsu.tula.ru/VNMT/Bulletin/E2015-4/5091.pdf doi: 10.12737/14918
  7. Voronina TA. The role of hypoxia in stroke and convulsive states. Antihypoxants. Obzory po klinicheskoy farmakologii i lekarstvennoy terapii. 2016;14(1):63-70. (In Russ.). doi:10.17816/RCF14163-70
  8. Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv. Рart 1. M. Grif i K; 2012. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.